ClinicalTrials.gov
ClinicalTrials.gov Menu

Nucleoside Switch Pilot for Virologically Controlled HIV Subjects With Decreasing CD4 Cells Who Have Received TDF-based ARV Therapy (EPZSwitch)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01608269
Recruitment Status : Completed
First Posted : May 31, 2012
Last Update Posted : April 28, 2017
Sponsor:
Information provided by (Responsible Party):
Therapeutic Concepts

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2012
  Actual Study Completion Date : October 2012